MRI-based tool to tell uterine sarcoma from fibroids
Part of Cancer, Skin clinical trials.
This trial uses MRI scans to see if a computer can tell the difference between uterine sarcoma (a rare cancer) and fibroids (non-cancerous growths). If you've already been diagnosed with one of these and had an MRI before surgery, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with uterine sarcoma or a fibroid (leiomyoma) after a biopsy.
- You had an MRI scan of your pelvis within 2 months before your surgery.
- The MRI included special sequences called T2-weighted and diffusion-weighted imaging.
- Your tumor must be at least 2 centimeters (about the size of a grape).
- The sarcoma started in your uterus, not elsewhere in your body.
- You do not have another type of cancer in your pelvis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI scans to improve how doctors tell the difference between benign uterine fibroids and rare uterine sarcomas. It may help avoid unnecessary surgeries or catch cancer earlier.
This study uses AI to look at CT scans from women with uterine sarcomas or fibroids to see if it can tell the difference between the two. The goal is to help doctors make a faster, more accurate diagnosis without needing surgery.
This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.
This study uses a special type of MRI called diffusion-weighted imaging (DWI) to look at the endometrium (the lining of the uterus) and help tell the difference between benign and cancerous growths. The results will be compared to a biopsy to see how accurate the MRI is.
This study tests a new MRI-based technique to better see the size and shape of bone sarcomas before surgery. The goal is to help surgeons remove all the cancer while saving as much healthy bone as possible.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
Hear when a new Uterine Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.